Elisa Fontana

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Elisa Fontana
Apr 19, 2025, 08:05 | Blog
Vivek Subbiah: Safety and activity of fibroblast growth factor receptor inhibitors in advanced malignancies
Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, posted on…
Apr 18, 2025, 19:10 | Science
Rafael Grochot: The safety and activity of FGFR inhibitors in early-phase clinical trials
Rafael Grochot, Medical Oncologist - Clinical Trial Specialist at Sarah Cannon Research Institute, shared a…
Jan 20, 2025, 13:49 | Opinion
5 Articles suggested by Wafik El-Deiry
Wafik S. El-Deiry, MD, PhD, FACP, FRSM, is the Associate Dean for Oncologic Sciences at…
Jan 4, 2025, 15:18 | Insight
Vivek Subbiah: Top Phase 1 clinical trial publications of 2024
Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute (USA), shared…
Sep 20, 2024, 17:05 | Blog
Florian Lordick: Lots of important data in gastrointestinal oncology at ESMO24
Florian Lordick, Oncologist, Professor of Medicine at University of Leipzig, shared a post on LinkedIn: "ESMO24…
Sep 11, 2024, 06:09 | Blog
Vivek Subbiah: First-in human phase 1 dose-escalation study of BT5528 in Patients With Advanced Solid Tumors
Vivek Subbiah shared a post on X: "Hot of the press - Pleased to share our…
Jul 1, 2024, 02:25 | Blog
Insights from ESMOGI24 by Cathy Eng
ESMO GI 2024 took place from June 26 to 29 in Munich, Germany, featuring both…
Jun 27, 2024, 08:20 | Societies
Insights from ESMOGI24 by Angela Lamarca
ESMO GI 2024 is taking place as an onsite event in Munich, Germany, from 26…
Oct 17, 2023, 01:32 | Blog
Vivek Subbiah: Awesome poster presentation on Epha2 targeting by our amazing Dr. Elisa Fontana
Vivek Subbiah shared on LinkedIn: "Kudos to our amazing Sarah Cannon Research Institute Phase 1 clinical…
All: 9 Posts: 1 - 100
Special Coverage